financetom
Business
financetom
/
Business
/
UnitedHealth's medical costs surge in third quarter, shares drop
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UnitedHealth's medical costs surge in third quarter, shares drop
Oct 15, 2024 3:34 AM

Oct 15 (Reuters) - UnitedHealth Group ( UNH ) reported a

surge in third-quarter medical costs on Tuesday, as the company

struggled with lower government payments in its insurance

business and persistently high demand for medical care, sending

its shares 3% lower.

For the quarter, the company's medical loss ratio - the

percentage of premiums spent on medical care - was 85.2%, higher

than the 82.3% reported a year earlier, as well as analysts'

estimate of 84.2%, according to data compiled by LSEG.

Demand for healthcare services under Medicare plans - for

people aged 65 years and older or those with disabilities - has

also exceeded industry expectations since late last year as

older adults underwent procedures they had postponed during the

pandemic.

The company also faced elevated medical costs as a turnover

in people enrolled in Medicaid left most health insurers with

more sick patients.

States have been reassessing enrollment for Medicaid plans

for low-income people since April last year, when a COVID-19

pandemic requirement that states keep consistent coverage of

participants lapsed.

UnitedHealth's ( UNH ) adjusted profit of $7.15 per share, however,

beat Wall Street estimates by 15 cents as the health

conglomerate, which also runs a healthcare services business,

saw increased membership across its businesses.

The company reported revenue of $100.8 billion, compared

with estimates of $99.28 billion.

(Reporting by Puyaan Singh and Leroy Leo in Bengaluru; Editing

by Shinjini Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China blames Netherlands for disrupting chip supply with Nexperia move
China blames Netherlands for disrupting chip supply with Nexperia move
Nov 3, 2025
BEIJING, Nov 4 (Reuters) - China has blamed the Netherlands for turmoil and chaos in the global semiconductor production and supply chain after the latter seized computer chipmaker Nexperia, the Chinese commerce ministry said on Tuesday. The ministry said Netherlands has acted alone, urging the Dutch government to stop interfering in the internal affairs of enterprises and to find a...
PRESS DIGEST-Wall Street Journal - November 4
PRESS DIGEST-Wall Street Journal - November 4
Nov 3, 2025
Nov 4 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Starbucks ( SBUX ) is selling a majority stake in its China retail operations to Boyu Capital, retaining 40%. - Denny's will be taken private in a $322 million deal, with...
BRIEF-Alcon Releases Investor Discussion Materials Reinforcing Certain Value Of Merger Proposal For Staar Stockholders
BRIEF-Alcon Releases Investor Discussion Materials Reinforcing Certain Value Of Merger Proposal For Staar Stockholders
Nov 3, 2025
Nov 4 (Reuters) - Alcon AG: * ALCON RELEASES INVESTOR DISCUSSION MATERIALS REINFORCING CERTAIN VALUE OF MERGER PROPOSAL FOR STAAR STOCKHOLDERS * ALCON AG - PROPOSED MERGER REPRESENTS A PREMIUM THAT SIGNIFICANTLY EXCEEDS MEDIAN PREMIUM OF COMPARABLE MEDTECH TRANSACTIONS AND OFFERS CERTAIN VALUE TO STAAR STOCKHOLDERS * ALCON AG - BROADWOOD HAS PROPOSED REMOVING STAAR BOARD MEMBERS AND INSTALLING ITS...
BRIEF-Alcon Releases Investor Discussion Materials of Merger Proposal for STAAR Stockholders
BRIEF-Alcon Releases Investor Discussion Materials of Merger Proposal for STAAR Stockholders
Nov 3, 2025
Nov 4 (Reuters) - ALCON AG: * ALCON RELEASES INVESTOR DISCUSSION MATERIALS REINFORCING CERTAIN VALUE OF MERGER PROPOSAL FOR STAAR STOCKHOLDERS * PLANS TO INITIATE OUTREACH TO STAAR STOCKHOLDERS AND PRESENTATION HIGHLIGHTS KEY CONSIDERATIONS FOR THESE DISCUSSIONS, INCLUDING * PROPOSED MERGER REPRESENTS A PREMIUM THAT SIGNIFICANTLY EXCEEDS MEDIAN PREMIUM OF COMPARABLE MEDTECH TRANSACTIONS AND OFFERS CERTAIN VALUE TO STAAR STOCKHOLDERS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved